Publications by authors named "Kelly Warfield"

Claim this Profile
P
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremia.
Christopher S Morello, Ravi Anantha, Jason E Comer, Jason Mendy, Lauren C Tindale, Kelly L Warfield

NPJ Vaccines· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humans.
Lark L Coffey, Katherine J Olstad, J Rachel Reader, Amir Ardeshir, Christopher M Weiss, Kelly L Warfield

Res Sq· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak.
Sabin Nsanzimana, Noella Bigirimana, Richard Hatchett, Sue Bailey, Natacha Butera, Kelly L Warfield

NPJ Vaccines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an adjuvanted chikungunya virus virus-like particle (CHIKV VLP) vaccine in previous recipients of other alphavirus vaccines versus alphavirus vaccine-naive controls: an open-label, parallel-group, age-matched, sex-matched, phase 2 randomised controlled study.
Melinda J Hamer, James M McCarty, Benjamin C Pierson, Jason A Regules, Jason Mendy, Kelly L Warfield

Lancet Microbe· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial.
Jason S Richardson, Deborah M Anderson, Jason Mendy, Lauren C Tindale, Sufia Muhammad, Kelly L Warfield

Lancet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Safety Assessment of the EBS-LASV Vaccine Candidate against Lassa Fever Virus.
Demetrius Matassov, Lisa Evans DeWald, Stefan Hamm, Rebecca M Nowak, Cheryl S Gerardi, Kelly Warfield

Vaccines (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals.
James M McCarty, Lisa Bedell, Jason Mendy, Emily E Coates, Grace L Chen, Kelly L Warfield

Vaccine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Two-Arm, Randomized, Double-Blind, Active-Controlled Study of Live, Oral Plasmid-Derived Adenovirus Type 4 and Type 7 Vaccines in Seronegative Adults.
Shannon Beaty, Natalie Collins, Nicos Karasavvas, Robert Kuschner, Jun Hang, Kelly Warfield

Vaccines (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Genome Replication of a Unique Single-Amino-Acid Mutation in the Adenovirus-4 Component of the Live Oral Adenovirus Type 4 and Type 7 Vaccine.
Natalie D Collins, Shannon Beaty, Elana Wallace, Yuanzhang Li, Mark Sanborn, Kelly Warfield

Vaccines (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.
Saravanan Raju, Lucas J Adams, James T Earnest, Kelly Warfield, Lo Vang

Sci Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy with UV-4B and Molnupiravir Enhances SARS-CoV-2 Suppression.
Evelyn J Franco, George L Drusano, Kaley C Hanrahan, Kelly L Warfield, Ashley N Brown

Viruses· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive and developmental toxicology studies of iminosugar UV-4.
Jeffry Shearer, Gary Wolfe, Mansoora Khaliq, Brian Kaufman, Aruna Sampath, Kelly L Warfield

Reprod Toxicol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An introduction to the Marburg virus vaccine consortium, MARVAC.
Robert W Cross, Ira M Longini, Stephan Becker, Karin Bok, David Boucher, Kelly L Warfield

PLoS Pathog· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial.
Sean R Bennett, James M McCarty, Roshan Ramanathan, Jason Mendy, Jason S Richardson, Kelly L Warfield

Lancet Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects.
Michael Callahan, Anthony M Treston, Grace Lin, Marla Smith, Brian Kaufman, Kelly L Warfield

PLoS Negl Trop Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational New Drug Enabling Nonclinical Safety Pharmacology Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent.
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman

Int J Toxicol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational New Drug Enabling Nonclinical Safety Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent.
Jeffry Shearer, Gary Wolfe, Aruna Sampath, Kelly L Warfield, Brian Kaufman

Int J Toxicol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines.
Danielle Thompson, Stefan W Metz, Carmen Abad, Shannon Beaty, Kelly Warfield

Vaccine· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UV-4B potently inhibits replication of multiple SARS-CoV-2 strains in clinically relevant human cell lines.
Evelyn J Franco, Kelly L Warfield, Ashley N Brown

Front Biosci (Landmark Ed)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
Sharanbasappa S Karade, Michelle L Hill, J L Kiappes, Rajkumar Manne, Balakishan Aakula, Kelly L Warfield

J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for McAllister et al., "Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors".
Nicole McAllister, Yan Liu, Lisete M Silva, Anthony J Lentscher, Wengang Chai, Kelly L Warfield

J Virol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iminosugars: A host-targeted approach to combat Flaviviridae infections.
Lisa Evans DeWald, Chloe Starr, Terry Butters, Anthony Treston, Kelly L Warfield

Antiviral Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
Nicole McAllister, Yan Liu, Lisete M Silva, Anthony J Lentscher, Wengang Chai, Kelly L Warfield

J Virol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections.
Kelly L Warfield, Dominic S Alonzi, Johan C Hill, Alessandro T Caputo, Pietro Roversi

J Med Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.
Jeffry D Shearer, Michelle L Saylor, Christine M Butler, Anthony M Treston, Henry S Heine, Kelly L Warfield

Antimicrob Agents Chemother· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis